Dexamethasone increases renal free fatty acids and xanthine oxidase activity in female rats: could there be any gestational impact?
Drug Chem Toxicol
; 45(2): 886-897, 2022 Mar.
Article
em En
| MEDLINE
| ID: mdl-32597234
ABSTRACT
Dexamethasone (DEX) is used for various conditions in female and even during pregnancy. We tested the hypothesis that DEX exposure in female rats would lead to renal free fatty acid (FFA) accumulation with elevated xanthine oxidase (XO) activity that would be aggravated by pregnancy. Twenty-four female rats (n = 6/group) were randomly assigned to non-pregnant (NPR), DEX-exposed non-pregnant (NPR + DEX), pregnant (PRE) and DEX-exposed pregnant (PRE + DEX), respectively. NPR and PRE rats received vehicle (po) while NPR + DEX and PRE + DEX groups received DEX (0.2 mg/kg; po), between gestational days 14 and 19. Data showed that DEX exposure caused increased plasma creatinine, urea, renal FFA accumulation, lipid peroxidation, aminotranferases, depressed glutathione, increased activity of XO, and elevated uric acid in both pregnant and non-pregnant rats. The findings of this study indicate that DEX exposure would cause renal FFA accumulation and glutathione depletion that are accompanied by increased activity of XO/uric acid independently of gestation. The study also implies that DEX-induced renal damage could be worsened by gestation.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Xantina Oxidase
/
Ácidos Graxos não Esterificados
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article